These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4145086)

  • 1. Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy.
    Podolsky S; Pattavina CG
    Metabolism; 1973 May; 22(5):685-93. PubMed ID: 4145086
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy.
    Nardone DA; Bouma DJ
    South Med J; 1979 Dec; 72(12):1607-8. PubMed ID: 515777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperosmolar hyperglycemic nonketotic coma. A complication of short-term systemic corticosteroid use.
    Fujikawa LS; Meisler DM; Nozik RA
    Ophthalmology; 1983 Oct; 90(10):1239-42. PubMed ID: 6657199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperglycemic coma without keto-acidosis in 2 hypertensive patients treated with intravenous diazoxide].
    Barjon P; Fourcade J; Monnier L; Mimran A; Taib J
    Sem Hop; 1973 Feb; 49(8):581-5. PubMed ID: 4349579
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperosmolar nonketotic coma in acromegaly.
    Milloy P
    JAMA; 1972 Nov; 222(7):814-6. PubMed ID: 4677933
    [No Abstract]   [Full Text] [Related]  

  • 6. No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
    Tötterman KJ; Groop LC
    Ann Clin Res; 1982 Aug; 14(4):190-3. PubMed ID: 6762846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adrenergic beta-blocker medication, formally contraindicated in all forms of diabetes mellitus?].
    Tacu V; Blum M; Tudor G; Mandric E
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(3):535-9. PubMed ID: 6152746
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorthalidone-induced hyperosmolar hyperglycemic nonketotic coma.
    Curtis J; Horrigan F; Ahearn D; Varney R; Sandler SG
    JAMA; 1972 Jun; 220(12):1592-3. PubMed ID: 4624522
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperosmolar non-ketotic diabetes mellitus associated with metolazone.
    Rowe PA; Mather HG
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):25-6. PubMed ID: 3926049
    [No Abstract]   [Full Text] [Related]  

  • 10. Nursing implications of hyperosmolar coma.
    Winters B
    Heart Lung; 1983 Jul; 12(4):439-46. PubMed ID: 6345470
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperosmolar nonketotic diabetic coma.
    Jackson WP; Forman R
    Diabetes; 1966 Oct; 15(10):714-22. PubMed ID: 5924833
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features of hyperosmolar hyperglycemic nonketotic diabetic coma associated with cardiac operations.
    Seki S
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):867-73. PubMed ID: 3520159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperglycemic hyperosmolar nonketotic coma].
    Miłkowska B; Ginel Z
    Wiad Lek; 1982 Oct; 35(17):1087-90. PubMed ID: 7179978
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperosmolar non-ketotic diabetic coma induced by furosemide in modest dosage.
    Khaleeli AA; Wyman AL
    Postgrad Med J; 1978 Jan; 54(627):43-4. PubMed ID: 625459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus.
    Micossi P; Pollavini G; Raggi U; Librenti MC; Garimberti B; Beggi P
    Horm Metab Res; 1984 Feb; 16(2):59-63. PubMed ID: 6368349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local and general non-immunologic complications of insulin therapy].
    Scapellato L
    Recenti Prog Med; 1973 Dec; 55(6):503-26. PubMed ID: 4592315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycemic, hyperosmolar nonketotic coma (HHNC).
    Kitabchi AE; Matteri R; Murphy MB
    Diabetes Care; 1982; 5 Suppl 1():78-87. PubMed ID: 6821307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and metabolic characteristics of hyperosmolar nonketotic coma.
    Gerich JE; Martin MM; Recant L
    Diabetes; 1971 Apr; 20(4):228-38. PubMed ID: 4994561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.